A potent transition-state analogue inhibitor of Escherichia coli asparagine synthetase A

Journal of the American Chemical Society

Volumn 121, Issue 24, 1999, Pages 5799-5800

  Koizumi, Mitsuteru ^a   Hiratake, Jun ^a   Nakatsu, Toru ^a   Kato, Hiroaki ^a   Oda, JuN'Ichi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMMONIA LIGASE; ENZYME INHIBITOR; S METHYLCYSTEINE SULFOXIMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CRYSTAL STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME INHIBITOR COMPLEX; ESCHERICHIA COLI; PHASE TRANSITION;

EID: 0033597605     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja990851a     Document Type: Article

References (29)

1. (a) Sugiyama, A.; Kato, H.; Nishioka, T.; Oda, J. Biosci. Biotechnol. Biochem. 1992, 56, 376-379.
2. (b) Hinchman, S. K.; Schuster, S. M. Protein Eng. 1992, 5, 279-283.
3. (a) Cedar, H.; Schwartz, J. H. J. Biol. Chem. 1969, 244, 4112-4121.
4. (b) Cedar, H.; Schwartz, J. H. J. Biol. Chem. 1969, 244, 4122-4127.
5. (c) Kim, S. II; Germond, J.-E.; Pridmore, D.; Söll, D. J. Bacteriol. 1996, 178, 2459-2461.
6. Richards, N. G. J.; Schuster, S. M. In Advances in Enzymology and Related Areas of Molecular Biology; Purich, D. L., Ed.; John Wiley: New York, 1998; Vol. 72: Amino Acid Metabolism, Part A, pp 145-198 and references therein.
7. Müller, H. J.; Boos, J. Crit. Rev. Oncol. Hematol. 1998, 28, 97-113.
8. (a) Nakatsu, T.; Kato H.; Oda, J. Nat. Struct. Biol. 1998, 5, 15-19.
9. (b) Hinchman, S. K.; Henikoff, S.; Schuster, S. M. J. Biol. Chem. 1992, 267, 144-149.
10. (c) Gatti, D. L.; Tzagoloff, A. J. Mol. Biol. 1991, 218, 557-568.
11. Luehr, C. A.; Schuster, S. M. Arch. Biochem. Biophys. 1985, 237, 335-346.
12. (a) Wolfenden, R. Annu. Rev. Biophys. Bioeng. 1976, 5, 271-306.
13. (b) Radzicka, A.; Wolfenden, R. Methods Enzymol. 1995, 249, 284-312.
14. (c) Schramm, V. L. Annu. Rev. Biochem. 1998, 67, 693-720.
15. Several aspartic acid analogues were synthesized as potential inhibitors of asparagine synthetase B (Parr, I. B.; Boehlein, S. K.; Dribben, A. B.; Schuster, S. M.; Richards, N. G. J. J. Med. Chem. 1996, 39, 2367-2378 and references therein).
16. (a) Pike, D. C.; Beevers, L. Biochim. Biophys. Acta 1982, 708, 203-209.
17. (b) Zhukov, Yu. N.; Biryukov, A. I.; Khomutov, R. M. Bioorg. Khim. 1988, 14, 969-972 (Chem. Abstr. 1988, 109, 207322w).
18. (b) Zhukov, Yu. N.; Biryukov, A. I.; Khomutov, R. M. Bioorg. Khim. 1988, 14, 969-972 (Chem. Abstr. 1988, 109, 207322w).
19. The amino group of adenine ring was unreactive under tetrazole- or tetrazolium salt-catalyzed phosphinylation conditions, and no protection was necessary.
20. 2+.
21. obs vs [1] showed no saturation.
22. i.
23. 2O.
24. L-Cysteine sulfoximine was reported to be a poor inhibitor of glutamine-dependent AS-B from mammalian pancreas (Jayaram, H. N.; Cooney, D. A. Cancer Treat. Rep. 1979, 63, 1095-1108).
25. Rowe, W. B.; Ronzio, R. A.; Meister, A. Biochemistry 1969, 8, 2674-2680.
26. (a) Tokutake, N.; Hiratake, J.; Katoh, M.; Irie, T.; Kato, H.; Oda, J. Bioorg. Med. Chem. 1998, 6, 1935-1953.
27. (b) Griffith, O. W. J. Biol. Chem. 1982, 257, 13704-13712.
28. + moiety of the tetrahedral intermediate and was shown to be responsible for stabilizing the transition state (Liaw, S.-H.; Eisenberg, D. Biochemistry 1994, 33, 675-681. Alibhai, M.; Villafranca, J. J. Biochemistry 1994, 33, 682- 686).
29. + moiety of the tetrahedral intermediate and was shown to be responsible for stabilizing the transition state (Liaw, S.-H.; Eisenberg, D. Biochemistry 1994, 33, 675-681. Alibhai, M.; Villafranca, J. J. Biochemistry 1994, 33, 682-686).